Nasdaq panel grants Bio-Path continued listing subject to $2.5M equity compliance by Jan 31, 2025

BIO-PATH HOLDINGS, INC.

Company must demonstrate minimum $2.5M stockholders' equity by Jan 31, 2025 to remain listed.
If conditions not met, Bio-Path may face delisting from Nasdaq Capital Market.
Company previously received deficiency notice in March 2024, extension in June 2024, and delisting determination in September 2024.
Bio-Path intends to pursue compliance but cautions there is no assurance of success.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.